According to MaxQ AI, the company took a year to prepare for ISO 27001 certification. MaxQ AI’s “security-by-design” approach is also paramount in this process as the company works to build security into every part of IT management and operations —sales, marketing, finance, and human resources. In addition, MaxQ AI has engaged its extensive network of global and trusted CT, PACS, and AI ecosystem partners to collaborate on comprehensive security solutions that ensure data integrity, monitoring, and access rights management.
MaxQ AI developed the ACCIPIO ICH and Stroke Platform, which integrates into a comprehensive, seamless, and secure workflow to augment acute care teams with deep clinical insight and actionable data in minutes. These AI-powered insights enable physicians across the world to make faster assessments of stroke, traumatic brain injury, and head trauma in any location, at any time.
Accipio Ix provides automatic identification and prioritization of non-contrast head CT images with suspected ICH. Accipio Ax delivers automatic slice-level annotation of suspected ICH. Both Accipio Ix and Ax are FDA and CE approved. The Accipio platform is comprised of Class II and Class III medical devices with significant clinical evidence.